Tech Company Inital Public Offerings
NextCure IPO
On 5/8/2019, NextCure went public.
Transaction Overview
Company Name
Announced On
5/8/2019
Transaction Type
IPO
Amount
$75,000,000
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds and cash on hand as follows: approximately $113.0 million to advance NC318 through completion of our ongoing Phase 1/2 clinical trial in patients with advanced or metastatic solid tumors and into a Phase 3 clinical trial; approximately $31.0 million to advance NC410 through completion of a Phase 1/2 clinical trial; and the remainder for research and development activities related to our FIND-IO platform and discovery programs, including advancement of two discovery programs through submission of INDs, personnel expenses, working capital and other general corporate purposes, including a $500,000 payment to Yale University that is due upon the closing of this offering.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
9000 Virginia Manor Rd. 200
New Haven, CT 20705
USA
New Haven, CT 20705
USA
Phone
Website
Email Address
Overview
NextCure (Nasdaq: NXTC), launched in 2015, is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Richman
Chief Financial Officer
Steven Cobourn
Vice President
Linda Liu
VP - Bus. Development
James Bingham
VP - Bus. Development
Sebastien Maloveste
VP - Bus. Development
Timothy Mayer
VP - Regulatory Affairs
Sol Langermann
Browse more venture capital transactions:
Prev: 5/8/2019: HeyJobs venture capital transaction
Next: 5/8/2019: Repair Biotechnologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs